More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Urology

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.juro.2016.10.067PMID 27984110PMCID PMC5315642
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Questioning the 10-year Life Expectancy Rule for High-grade Prostate Cancer: Comparative Effectiveness of Aggressive vs Nonaggressive Treatment of High-grade Disease in Older Men With Differing Comorbid Disease Burdens.

  2016cited by this paper
• Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Prostate Cancer, Version 1.2016.

  2016cited by this paper
• Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.

  2015cited by this paper
• Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.

  2015cited by this paper
• Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.

  2015influential reference
• Increasing use of observation among men at low risk for prostate cancer mortality.

  2015cited by this paper
• Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer.

  2015cited by this paper
• Comparative effectiveness of aggressive versus nonaggressive treatment among men with early‐stage prostate cancer and differing comorbid disease burdens at diagnosis

  2014cited by this paper
• Radical prostatectomy or watchful waiting in early prostate cancer.

  2014cited by this paper
• in Population–Based Cohort of Men With Prostate Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

  2013cited by this paper
• Long-term functional outcomes after treatment for localized prostate cancer.

  2013cited by this paper
• Erratum: An updated prostate cancer staging nomogram (partin tables) based on cases from 2006 to 2011 (BJU International 111 (22-29))

  2013cited by this paper
• Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.

  2013cited by this paper
• An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011

  2013cited by this paper
• Radical prostatectomy versus observation for localized prostate cancer.

  2012cited by this paper
• Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram

  2012cited by this paper
• Trends in the treatment of localized prostate cancer using supplemented cancer registry data

  2011cited by this paper
• Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.

  2011cited by this paper
• Time trends and local variation in primary treatment of localized prostate cancer.

  2010cited by this paper
• Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

  2009cited by this paper
• What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.

  2007cited by this paper
• The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

  2005cited by this paper
• Prostate cancer and the Will Rogers phenomenon.

  2005cited by this paper
• 20-year outcomes following conservative management of clinically localized prostate cancer.

  2005cited by this paper
• The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

  2004cited by this paper
• Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study.

  1999cited by this paper
• Cancer statistics

  1989cited by this paper

• Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis

  2023cites this paper
• Systematic Review of cost-effectiveness models in prostate cancer: exploring new developments in testing and diagnosis

  2020cites this paper
• The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.

  2020cites this paper
• Comparing the Effects of Surgery, Radiation Therapy, and Active Surveillance on Men with Localized Prostate Cancer -- The CEASAR Study

  2020cites this paper
• Radical prostatectomy versus deferred treatment for localised prostate cancer.

  2020cites this paper
• Interpretation of domain scores on the expanded prostate cancer index composite: How does the domain score translate into functional outcomes?

  2019cites this paper
• Prostate cancer management choices in patients undergoing multiparametric magnetic resonance imaging/ultrasound fusion biopsy compared to systematic biopsy.

  2018cites this paper
• Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer

  2018cites this paper
• Quality of care and economic considerations of active surveillance of men with prostate cancer

  2018cites this paper
• Cost‐Effectiveness of Urinary Biomarker Panel in Prostate Cancer Risk Assessment

  2018cites this paper
• Oncology: Prostate/Testis/Penis/Urethra Interpretation of Domain Scores on the EPICdHow Does the Domain Score Translate into Functional Outcomes?

  year unknowncites this paper